总经费近10亿元!2017年针对中医中药的国家重点研发计划项目出炉

2017-12-14 MedSci MedSci

今年5月底到6月初以及11月份,科技部相继公示了2017年国家重点研发计划40多个重点专项的立项清单,公示项目的总经费近230亿元。今天(12月13日),科技部又公示了一批国家重点研发计划重点专项2017年项目,本次共有60个项目入选,项目总金额达到9.94亿元。全新的国家重点研发计划在中国现有的科研体制中一直存在着科技计划体系的重复、分散等问题。为解决这一问题,同时提高财政资金使用效益,国务院于

今年5月底到6月初以及11月份,科技部相继公示了2017年国家重点研发计划40多个重点专项的立项清单,公示项目的总经费近230亿元。

今天(12月13日),科技部又公示了一批国家重点研发计划重点专项2017年项目,本次共有60个项目入选,项目总金额达到9.94亿元。

全新的国家重点研发计划


在中国现有的科研体制中一直存在着科技计划体系的重复、分散等问题。为解决这一问题,同时提高财政资金使用效益,国务院于2014年部署国家科技计划管理改革,计划在2016年底前完成改革主体任务,将原有的100多个科技计划整合成国家自然科学基金、国家科技重大专项、国家重点研发计划、技术创新引导专项(基金)、基地和人才专项五大类。

2014年国家科技体制改革后,原国家“973”计划、“863”计划、科技支撑计划以及各部委相关计划整合形成了现在的国家重点研发计划。2015年底和2016年初,国家分别启动了2016年度国家重点研发计划的试点专项和重点专项评审工作。科技部6个试点专项和36个重点专项一共批复立项1172个项目,项目总经费约278亿元。

18个项目总经费超8亿元

本次公示的项目集中在中医药现代化研究和食品安全关键技术研发两个领域,本次共有60个项目入选,项目总金额达到9.94亿元。

从获批项目的所在单位来看,北京中医药大学、上海中医药大学、长春中医药大学、成都中医药大学、江南大学、复旦大学等中医药或食品领域实力较强的近20所高校入选。最新获批的国家重点研发计划项目的详细名单如下:




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1928491, encodeId=0cb7192849156, content=<a href='/topic/show?id=42174099183' target=_blank style='color:#2F92EE;'>#国家重点研发计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40991, encryptionId=42174099183, topicName=国家重点研发计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sat Sep 15 10:15:00 CST 2018, time=2018-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814706, encodeId=b31e1814e0695, content=<a href='/topic/show?id=8aa095900c4' target=_blank style='color:#2F92EE;'>#重点研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95900, encryptionId=8aa095900c4, topicName=重点研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b0e350, createdName=naiwu77, createdTime=Sat Oct 06 00:15:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957450, encodeId=1b84195e45084, content=<a href='/topic/show?id=5fe04098847' target=_blank style='color:#2F92EE;'>#国家重点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40988, encryptionId=5fe04098847, topicName=国家重点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jul 23 10:15:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300098, encodeId=ea84130009855, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602753, encodeId=a4411602e5307, content=<a href='/topic/show?id=ea452139631' target=_blank style='color:#2F92EE;'>#中医中药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21396, encryptionId=ea452139631, topicName=中医中药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ca18907650, createdName=venlin, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1928491, encodeId=0cb7192849156, content=<a href='/topic/show?id=42174099183' target=_blank style='color:#2F92EE;'>#国家重点研发计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40991, encryptionId=42174099183, topicName=国家重点研发计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sat Sep 15 10:15:00 CST 2018, time=2018-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814706, encodeId=b31e1814e0695, content=<a href='/topic/show?id=8aa095900c4' target=_blank style='color:#2F92EE;'>#重点研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95900, encryptionId=8aa095900c4, topicName=重点研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b0e350, createdName=naiwu77, createdTime=Sat Oct 06 00:15:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957450, encodeId=1b84195e45084, content=<a href='/topic/show?id=5fe04098847' target=_blank style='color:#2F92EE;'>#国家重点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40988, encryptionId=5fe04098847, topicName=国家重点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jul 23 10:15:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300098, encodeId=ea84130009855, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602753, encodeId=a4411602e5307, content=<a href='/topic/show?id=ea452139631' target=_blank style='color:#2F92EE;'>#中医中药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21396, encryptionId=ea452139631, topicName=中医中药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ca18907650, createdName=venlin, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1928491, encodeId=0cb7192849156, content=<a href='/topic/show?id=42174099183' target=_blank style='color:#2F92EE;'>#国家重点研发计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40991, encryptionId=42174099183, topicName=国家重点研发计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sat Sep 15 10:15:00 CST 2018, time=2018-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814706, encodeId=b31e1814e0695, content=<a href='/topic/show?id=8aa095900c4' target=_blank style='color:#2F92EE;'>#重点研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95900, encryptionId=8aa095900c4, topicName=重点研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b0e350, createdName=naiwu77, createdTime=Sat Oct 06 00:15:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957450, encodeId=1b84195e45084, content=<a href='/topic/show?id=5fe04098847' target=_blank style='color:#2F92EE;'>#国家重点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40988, encryptionId=5fe04098847, topicName=国家重点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jul 23 10:15:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300098, encodeId=ea84130009855, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602753, encodeId=a4411602e5307, content=<a href='/topic/show?id=ea452139631' target=_blank style='color:#2F92EE;'>#中医中药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21396, encryptionId=ea452139631, topicName=中医中药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ca18907650, createdName=venlin, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1928491, encodeId=0cb7192849156, content=<a href='/topic/show?id=42174099183' target=_blank style='color:#2F92EE;'>#国家重点研发计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40991, encryptionId=42174099183, topicName=国家重点研发计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sat Sep 15 10:15:00 CST 2018, time=2018-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814706, encodeId=b31e1814e0695, content=<a href='/topic/show?id=8aa095900c4' target=_blank style='color:#2F92EE;'>#重点研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95900, encryptionId=8aa095900c4, topicName=重点研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b0e350, createdName=naiwu77, createdTime=Sat Oct 06 00:15:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957450, encodeId=1b84195e45084, content=<a href='/topic/show?id=5fe04098847' target=_blank style='color:#2F92EE;'>#国家重点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40988, encryptionId=5fe04098847, topicName=国家重点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jul 23 10:15:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300098, encodeId=ea84130009855, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602753, encodeId=a4411602e5307, content=<a href='/topic/show?id=ea452139631' target=_blank style='color:#2F92EE;'>#中医中药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21396, encryptionId=ea452139631, topicName=中医中药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ca18907650, createdName=venlin, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=)]
    2017-12-16 lqvr
  5. [GetPortalCommentsPageByObjectIdResponse(id=1928491, encodeId=0cb7192849156, content=<a href='/topic/show?id=42174099183' target=_blank style='color:#2F92EE;'>#国家重点研发计划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40991, encryptionId=42174099183, topicName=国家重点研发计划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Sat Sep 15 10:15:00 CST 2018, time=2018-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1814706, encodeId=b31e1814e0695, content=<a href='/topic/show?id=8aa095900c4' target=_blank style='color:#2F92EE;'>#重点研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95900, encryptionId=8aa095900c4, topicName=重点研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b0e350, createdName=naiwu77, createdTime=Sat Oct 06 00:15:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957450, encodeId=1b84195e45084, content=<a href='/topic/show?id=5fe04098847' target=_blank style='color:#2F92EE;'>#国家重点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40988, encryptionId=5fe04098847, topicName=国家重点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Mon Jul 23 10:15:00 CST 2018, time=2018-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300098, encodeId=ea84130009855, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602753, encodeId=a4411602e5307, content=<a href='/topic/show?id=ea452139631' target=_blank style='color:#2F92EE;'>#中医中药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21396, encryptionId=ea452139631, topicName=中医中药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ca18907650, createdName=venlin, createdTime=Sat Dec 16 01:15:00 CST 2017, time=2017-12-16, status=1, ipAttribution=)]

相关资讯

“中医针灸全球风采行”走进24个国家和地区

在世界针灸学会联合会成立30周年之际,由世界针灸学会联合会、中国中医科学院、世界卫生组织联合主办,中国针灸学会 、中国中医科学院针灸研究所承办的世界针灸学术大会暨2017中国针灸学会学术年会于近日在北京开幕。

中医框架下 健康产业大有可为

随着健康产业服务范围的扩大,健康旅游、健康资本、健康大数据、医养结合等逐步融入健康产业服务,而中医药在这些方面都有自己的独特优势,可以古为今用,中为洋用。日前,由中华中医药学会主办、广东省中医院承办的“2017国家健康产业论坛”在海口召开,与会专家探讨了中医药在健康产业发展中的作用和优势。

卫计委发布中医诊所新标准!

重磅消息来了,今日上午,国家卫计委发布了《中医诊所基本标准》和《中医(综合)诊所基本标准》,想开中医诊所和中西医服务诊所的人看过来!

中医专长培训班?别上当!

随着近期《中医医术确有专长人员医师资格考核注册管理暂行办法》的出台,社会上有很多培训机构通过微信群或微信公众号、网络网站、电话、传单等途径,擅自解释中医医术确有专长人员医师资格考核政策、标准和考务细则,向社会发出虚假信息,宣称只要你参加其举办的中医师承或中医医术确有专长培训,就保证能够通过考核取得中医医术确有专长医师资格证书,并以此为名收取巨额培训费。

国家中医药管理局:到2020年实现人人基本享有中医药服务

12月8日,国家中医药管理局网站发布《关于推进中医药健康服务与互联网融合发展的指导意见》。意见指出,到2020年,中医药健康服务与互联网融合发展迈上新台阶,融合发展新模式广泛应用,服务内容不断丰富,领域不断拓展,水平加快提升,线上线下结合更加紧密,产业链逐步形成,治理能力现代化水平明显提升,健康服务能力明显增强,实现人人基本享有中医药服务。到2030年,以中医药理论为指导、互联网为依托、融入现

两类中医诊所基本标准出台

近日,国家卫生计生委、国家中医药管理局印发《中医诊所基本标准》和《中医(综合)诊所基本标准》。继上月国家卫生计生委公布《中医诊所备案管理暂行办法》,并于本月1日起施行传统纯中医诊所备案管理后,开设中医诊所的标准进一步明晰。根据上述标准,今后开设传统纯中医诊所,将在房间设置等方面取消许多“硬杠杠”。此次印发的诊所标准分为两类:一类是在中医药理论指导下,运用中药和针灸、拔罐、推拿等非药物疗法开展诊疗